You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. High-affinity monoclonal antibodies that target Burkholderia Polysaccharide

    SBC: DxDiscovery Incorporated            Topic: CBD14105

    The purpose of this contract is to develop high affinity antibodies that are specific to Burkholderia surface expressed polysaccharides. These monoclonal antibodies (mAbs) can then be used to develop diagnostics and therapeutics for melioidosis and glanders; two infectious diseases caused by the Tier 1 biothreats Burkholderia pseudomallei and mallei, respectively. The SBIR funded work to date deve ...

    SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
  2. Enhanced Canine Performance, Protection and Survivability

    SBC: Oceanit Laboratories, Inc.            Topic: SOCOM172002

    Oceanit proposes to develop novel nutraceutical and/or pharmaceuticals to enhance important USSOCOM Multi-Purpose Canine (MPC) performance attributes that optimize their performance, improve recovery time when wounded and increase their survivability.

    SBIR Phase I 2018 Department of DefenseSpecial Operations Command
US Flag An Official Website of the United States Government